Literature DB >> 12216750

Sonography of diffuse liver disease.

Hisham Tchelepi1, Philip W Ralls, Randall Radin, Edward Grant.   

Abstract

Sonography is often the first imaging procedure performed in the evaluation of individuals with suspected liver disease. Evaluation for biliary dilatation is always performed, because bile duct obstruction can cause abnormal liver test results, raising the suspicion of liver disease. Ultrasound is a useful but imperfect tool in evaluating diffuse liver disease. We discuss the uses and limitations of sonography in evaluating parenchymal liver disease. Sonography can show hepatomegaly, fatty infiltration of the liver, and cirrhosis, all with good but imperfect sensitivity and specificity. Sonography is of limited usefulness in acute hepatitis. Increased parenchymal echogenicity is a reliable criterion for diagnosing fatty liver. Cirrhosis can be diagnosed in the correct clinical setting when the following are present: a nodular liver surface, decreased right lobe-caudate lobe ratio, and indirect evidence of portal hypertension (collateral vessels and splenomegaly). Ultrasound plays an important role in the imaging of conditions and procedures common in patients with diffuse liver disease.

Entities:  

Mesh:

Year:  2002        PMID: 12216750     DOI: 10.7863/jum.2002.21.9.1023

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  63 in total

1.  Automated classification of liver disorders using ultrasound images.

Authors:  Fayyaz ul Amir Afsar Minhas; Durre Sabih; Mutawarra Hussain
Journal:  J Med Syst       Date:  2011-11-10       Impact factor: 4.460

2.  Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.

Authors:  Meral Gunay-Aygun; Baris I Turkbey; Joy Bryant; Kailash T Daryanani; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Theo Heller; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-09-08       Impact factor: 4.797

Review 3.  The role of abdominal ultrasound in the diagnosis, staging and management of cystic fibrosis liver disease.

Authors:  Louise Stewart
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

4.  Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.

Authors:  Claudio Tana; Marco Tana; Stefano Rossi; Mauro Silingardi; Cosima Schiavone
Journal:  J Ultrasound       Date:  2016-03-29

5.  Obstetric Outcome in Women with Chronic Liver Disease.

Authors:  Pinky Jena; C N Sheela; Rao Preethi Venkatachala; Harshad Devarbhavi
Journal:  J Obstet Gynaecol India       Date:  2016-12-26

6.  Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

Authors:  Aliya Qayyum; Daryl M Chen; Richard S Breiman; Antonio C Westphalen; Benjamin M Yeh; Kirk D Jones; Ying Lu; Fergus V Coakley; Peter W Callen
Journal:  Clin Imaging       Date:  2009 Mar-Apr       Impact factor: 1.605

7.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

8.  Portalsystemic hemodynamic changes in chronic severe hepatitis B: An ultrasonographic study.

Authors:  Zhong-Zhen Su; Hong Shan; Wei-Min Ke; Bing-Jun He; Rong-Qin Zheng
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.

Authors:  Goutam Ghoshal; Roberto J Lavarello; Jeremy P Kemmerer; Rita J Miller; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2012-10-11       Impact factor: 2.998

10.  Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis.

Authors:  Lei Shen; Ji-Qiang Li; Min-De Zeng; Lun-Gen Lu; Si-Tao Fan; Han Bao
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.